About Us

Founded in 1995, Lawley Pharmaceuticals is a privately owned, Perth-based Australian company and a global leader in the research and development of transdermal androgen hormone therapies for both women and men.

In 2020, over two decades of dedication culminated in Australian regulatory approvals that marked global breakthroughs in androgen hormone treatment.

Our innovative androgen hormone therapy for women represents a world-first regulatory approval for managing hypoactive sexual desire dysfunction in postmenopausal women.

For men, our low-dose scrotal androgen hormone application offers a fast-absorbing, cost-effective solution with an enhanced safety profile—minimising third-party passive transfer and reducing treatment costs for patients and healthcare systems.

At Lawley, we believe in working with the body—not against it—by delivering androgen hormone therapies that are body-identical, effective, and trusted.